AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 89 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $42,000 | -26.3% | 67,500 | 0.0% | 0.00% | – |
| Q3 2019 | $57,000 | -70.8% | 67,500 | -76.7% | 0.00% | – |
| Q2 2019 | $195,000 | +143.8% | 289,856 | +196.4% | 0.00% | – |
| Q1 2019 | $80,000 | -92.8% | 97,789 | -86.0% | 0.00% | -100.0% |
| Q4 2018 | $1,116,000 | -43.1% | 697,500 | +17.7% | 0.00% | 0.0% |
| Q3 2018 | $1,961,000 | +1385.6% | 592,442 | +913.4% | 0.00% | – |
| Q2 2018 | $132,000 | -88.5% | 58,459 | -85.2% | 0.00% | -100.0% |
| Q1 2018 | $1,149,000 | +34.9% | 396,202 | +29.7% | 0.00% | 0.0% |
| Q4 2017 | $852,000 | -27.0% | 305,481 | -4.5% | 0.00% | 0.0% |
| Q3 2017 | $1,167,000 | – | 319,900 | +615092.3% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 52 | -99.9% | 0.00% | – |
| Q2 2014 | $86,000 | +4200.0% | 86,325 | +3832.8% | 0.00% | – |
| Q1 2014 | $2,000 | +100.0% | 2,195 | +67.7% | 0.00% | – |
| Q4 2013 | $1,000 | 0.0% | 1,309 | +153.2% | 0.00% | – |
| Q3 2013 | $1,000 | -96.0% | 517 | -94.7% | 0.00% | – |
| Q2 2013 | $25,000 | – | 9,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
| X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
| WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
| Caption Management, LLC | 855,200 | $701,000 | 0.04% |
| Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
| Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |